World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
26097
World Ranking
3925
National Ranking
1799

Natalie J. Thornburg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Natalie J. Thornburg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 190 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Natalie J. Thornburg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Natalie J. Thornburg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Natalie J. Thornburg is affiliated with the Centers for Disease Control and Prevention in the United States. Their research spans a significant range of topics primarily within medicine, with a strong focus on infectious diseases and epidemiology.

Thornburg's work prominently features studies on SARS-CoV-2 and COVID-19, including detection, testing, and clinical research. Their scientific output includes a substantial volume of publications related to respiratory viral infections and viral gastroenteritis epidemiology, as well as biosensors and analytical detection technologies.

The main fields and subfields of study represented in Thornburg's publications are:

  • Medicine
  • Infectious Diseases
  • Epidemiology
  • Modeling and Simulation
  • Pulmonary and Respiratory Medicine
  • Biomedical Engineering

Major research topics covered include:

  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Biosensors and Analytical Detection

Thornburg has published in a range of scientific venues, with frequent contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • MMWR Morbidity and Mortality Weekly Report
  • Open Forum Infectious Diseases
  • Emerging Infectious Diseases

Frequent co-authors working alongside Thornburg include Jennifer L. Harcourt, Azaibi Tamin, Sandra Lester, Aron J. Hall, and Lisa Mills, reflecting collaboration within the field of infectious disease research.

Selected notable recent publications authored or co-authored by Thornburg are:

  • Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1, 2020, New England Journal of Medicine
  • Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility, 2020, New England Journal of Medicine
  • An Orally Bioavailable Broad-Spectrum Antiviral Inhibits SARS-CoV-2 in Human Airway Epithelial Cell Cultures and Multiple Coronaviruses in Mice, 2020, Science Translational Medicine
  • Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020, 2020, JAMA Internal Medicine
  • US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2, 2020, Emerging Infectious Diseases

Best Publications

  • Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

    Neeltje van Doremalen;Trenton Bushmaker;Dylan H. Morris;Myndi G. Holbrook

  • Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

    Melissa M. Arons;Kelly M. Hatfield;Sujan C. Reddy;Anne Kimball

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

    Fiona P. Havers;Carrie Reed;Travis Lim;Joel M. Montgomery

  • US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

    Xiaoyan Lu;Lijuan Wang;Senthilkumar K. Sakthivel;Brett Whitaker

  • Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.

    Jennifer Harcourt;Jennifer Harcourt;Azaibi Tamin;Xiaoyan Lu;Shifaq Kamili

  • The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

    Nadine G Rouphael;Michele Paine;Regina Mosley;Sebastien Henry

  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

    Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  • First 12 patients with coronavirus disease 2019 (COVID-19) in the United States

    Stephanie A. Kujawski;Karen K Wong;Jennifer P. Collins;Lauren Epstein

  • Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.

    Kristina L. Bajema;Ryan E. Wiegand;Kendra Cuffe;Sadhna V. Patel

  • 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

    Jens H. Kuhn;Scott Adkins;Daniela Alioto;Sergey V. Alkhovsky

  • Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.

    Ian W Pray;Laura Ford;Devlin Cole;Christine Lee

  • Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1

    Neeltje Van Doremalen;Trenton Bushmaker;Dylan H. Morris;Myndi G. Holbrook

  • Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.

    Jessica L. Prince-Guerra;Olivia Almendares;Leisha D. Nolen;Jayleen K.L. Gunn

  • SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020.

    Daniel C. Payne;Sarah E. Smith-Jeffcoat;Gosia Nowak;Uzo Chukwuma

  • Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection.

    Unknown

  • Activation of Nuclear Factor-κB p50 Homodimer/Bcl-3 Complexes in Nasopharyngeal Carcinoma

    Natalie J. Thornburg;Rajadurai Pathmanathan;Nancy Raab-Traub

  • Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.

    Wesley H. Self;Mark W. Tenforde;William B. Stubblefield;Leora R. Feldstein

  • Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

    Jefferson M Jones;Mars Stone;Hasan Sulaeman;Rebecca V Fink

  • Household Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 in the United States.

    Nathaniel M Lewis;Nathaniel M Lewis;Victoria T Chu;Dongni Ye;Erin E Conners

  • Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

    Unknown

  • Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

    Jennifer Harcourt;Azaibi Tamin;Xiaoyan Lu;Shifaq Kamili

  • Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network-12 States, April-August 2020

    Wesley H Self;Mark W Tenforde;William B Stubblefield;Leora R Feldstein

  • Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.

    Manish M. Patel;Natalie J. Thornburg;William B. Stubblefield;H. Keipp Talbot

Frequent Co-Authors

Susan I. Gerber
Susan I. Gerber Centers for Disease Control and Prevention
Aron J. Hall
Aron J. Hall Centers for Disease Control and Prevention
Jacqueline E. Tate
Jacqueline E. Tate Centers for Disease Control and Prevention
Alicia M. Fry
Alicia M. Fry Emory University
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Stephen Lindstrom
Stephen Lindstrom Centers for Disease Control and Prevention
L. Clifford McDonald
L. Clifford McDonald Centers for Disease Control and Prevention
Paul A. Rota
Paul A. Rota Centers for Disease Control and Prevention
Manish M. Patel
Manish M. Patel Centers for Disease Control and Prevention
Michael D. Bowen
Michael D. Bowen Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Natalie J. Thornburg

Trending Scientists

Recently Published Articles